ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Walgreens Boots Alliance, Inc. (“Walgreens” or “the Company”) (NASDAQ: WBA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company’s securities between April 2, 2020 and January 16, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before March 31, 2025.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Walgreens promised to improve its regulatory compliance, yet regularly engaged in violations of federal law related to dispensing of prescription medications. The Company’s conduct exposed it to a heightened risk of regulatory scrutiny. The Company’s revenue from the sale of prescription medications was not sustainable due to the extent of unlawful conduct. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Walgreens, investors suffered damages.
